欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/3650/001
药品名称
Memantin Aristo 5 mg Filmtabletten
活性成分
memantine hydrochloride 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Aristo Pharma GmbH Wallenroder Str. 8-10 D-13435 Berlin Germany
参考成员国 - 产品名称
Germany (DE)
Memantin Aristo 5 mg Filmtabletten
互认成员国 - 产品名称
许可日期
2013/05/14
最近更新日期
2023/05/20
药物ATC编码
N06DX01 memantine
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_blister_fcte_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_inner_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_outer_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_outer_oso_cv__20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3649_Memantin_Neuraxpharm_pl_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3649_Memantin_Neuraxpharm_pl_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3649_Memantin_Neuraxpharm_spc_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3649_Memantin_Neuraxpharm_spc_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_bl_fct_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_bl_initiation_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_inner_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_outer_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_outer_initiation_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_3650_Memantin Aristo_outer_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3650_Memantin Aristo_pl_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3650_Memantin Aristo_pl_initiation_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_3650_Memantin Aristo_pl_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3650_Memantin Aristo_spc_fct_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3650_Memantin Aristo_spc_initiation_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_3650_Memantin Aristo_spc_oso_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_5051_Memantin_Neuraxpharm_impack_odt_cv_20170907_renewal
Date of last change:2024/09/06
Final Labelling
|
DE_5051_Memantin_Neuraxpharm_outer_odt_cv_20170907_renewal
Date of last change:2024/09/06
Final PL
|
DE_5051_Memantin_Neuraxpharm_pl_memantin_odt_cv_20170907_renewal
Date of last change:2024/09/06
Final SPC
|
DE_5051_Memantin_Neuraxpharm_spc_memantin_odt_cv_20170907_renewal
Date of last change:2024/09/06
PubAR
|
PAREN_DE3650_Memantin_neuraxpharm_20140116
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase